Co-registration of PET and MRI in different courses of MS using Cobalt-55 as a Calcium-tracer

Acta Neurologica Belgica

Volumn 97, Issue 3, 1997, Pages 178-182

  Jansen, H M L ^a,b   Decoo, D ^a   Minderhoud, J M ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cobalt PET; Image fusion; MRI; Multiple Sclerosis

Indexed keywords

CALCIUM; COBALT; DIAGNOSTIC AGENT;

ARTICLE; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; INFLAMMATION; METABOLISM; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SCINTISCANNING; T LYMPHOCYTE; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

BRAIN; CALCIUM; COBALT RADIOISOTOPES; HUMANS; INFLAMMATION; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; T-LYMPHOCYTES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0031228053     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ANTEL J. P., BECHER B. and OWENS T. Immunotherapy for multiple sclerosis : from theory to practice. Nature Medicine, 1996, 2 : 1074-1075.
2. FILIPPI M., YOUSRY T., CAMPI A., KANDZIORA C., COLOMBO B. et al. Comparison of triple dose versus standard dose Gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology, 1996, 46 : 379-384.
3. KIDD D., THORPE J. W., KEUDALL B. E., BARKER G. J., MILLER D. H. et al. MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psych, 1996, 60 : 15-19.
4. KOZIOL J. A., FRUTOS A., SIPE J. C., ROMINE J. S. and BELTZER E. A comparison of two neurologic scoring instruments for multiple sclerosis. J Neurol, 1996, 243 : 209-213.
5. KURTZKE J. F. Rating neurologic impairment in multiple sclerosis : an expanded disability status scale (EDSS). Neurology, 1983, 33 : 1444 - 1452.
6. LUBLIN F. D., WHITAKER I. N., EIDERMAN B. H., MILLER A. E., ARNASON B. G. W. et al. Management of patient receiving interferon beta or multiple sclerosis. Neurology, 1996, 46 : 12-18.
7. LUBLIN F. D., REINGOLD S. C. Defining the clinical course of Multiple Sclerosis. Neurology, 1996, 46 : 907-911.
8. MARTINO G., CLEMENTI E., BRAMBILLA E., MOIOLA L., COMI G. et al. γ-Interferon activates a previously undescribed Ca-influx in T lymphocytes from patients with multiple sclerosis. Proc Natl Acad Sci USA, 1994, 91 : 4825-4829.
9. MARTINO G., BRAMBILLA E., FILIPPI M., MARTINELLI V., COLOMBO B. et al. Interferon-γ activated calcium influx in peripheral blood lymphocytes form patients with primary and secondary progressive multiple sclerosis. J Neurol Neurosurg Psych, 1996a, 61 : 515-517.
10. MARTINO G., FILIPPI M., MARTINELLI V., BRAMBILLA E., COMI G. et al. Clinical and radiologic correlates of a novel T lymphocyte γ-interferon-activated Ca-influx in patients with relapsing-remitting multiple sclerosis. Neurology, 1996b, 46 : 1416-1421.
11. MILLER D. H., ALBERT P. S., BORKHOF F., FRANCIS G., FRANK J. A. et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of Multiple Sclerosis. Ann Neurol, 1996, 39 : 6-16.
12. MINDERHOUD J. M. On the pathogenesis of multiple sclerosis. A revised model of the cause(s) of multiple sclerosis, especially based on epidemiological data. Clin Neurol Neurosurg, 1994, 96 : 135-142.
13. MOREAU T., THORPE J., MILLER D., MOSELY I., HAI E G. et al. Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet, 1994, 344 : 298-301.
14. POSER C. M., PATY D. W., SCHEINBERG L., Mc. DONALD W. I., DAVIS F. A. et al. New diagnostic criteria for multiple sclerosis : guidelines for research protocols. Ann Neurol, 1983, 133 : 227-231.
15. SIPE J. C., KNOBLER R. L., BRAHFNY S. L., RICE G. P. A., PANITCH H. S. et al. A neurologic rating scale (MRS) for use in multiple sclersis. Neurology, 1984, 34: 1368-1372.
16. THORPE J. W., KIDD D., MOSELEY I. F., KENDALL B. E., THOMPSON A. J. et al. Serial Gadoliniumenhanced MRI of the brain and spinal cord in early relapsing-remitting Multiple Sclerosis. Neurology, 1996, 46 : 373-378.
17. WADE D. T. Epidemiology of disabling neurological disease : how and why does disability occur ? J Neurol Neurosurg Psych, 1996, 61 : 242-249.
18. WEINSHENKER B. G., ISSA M. and BASKERVILLE I. Meta-analysis of the placebo-treated groups in clinical trials of progressive MS. Neurology, 1996, 46 : 1613-1619.